13075_2017_1267_MOESM2_ESM.pdf (16.66 kB)
Download file

Additional file 2: Figure S2. of Phase 1b randomized, double-blind study of namilumab, an anti-granulocyte macrophage colony-stimulating factor monoclonal antibody, in mild-to-moderate rheumatoid arthritis

Download (16.66 kB)
journal contribution
posted on 09.03.2017, 05:00 authored by T. Huizinga, A. Batalov, R. Stoilov, E. Lloyd, T. Wagner, D. Saurigny, B. Souberbielle, E. Esfandiari
Flow diagram showing patient disposition. DMARDs disease-modifying antirheumatic drugs, HIV human immunodeficiency virus, IgG, immunoglobulin G (PDF 16 kb)

Funding

Takeda Pharmaceutical Company

History